Panagora Asset Management’s Xenetic Biosciences XBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-34
Closed -$4K 2646
2019
Q2
$4K Sell
34
-102
-75% -$13.5K ﹤0.01% 2495
2019
Q1
$32K Buy
136
+34
+33% +$8.32K ﹤0.01% 2161
2018
Q4
$20K Buy
102
+10
+11% +$3.03K ﹤0.01% 2222
2018
Q3
$31K Buy
92
+40
+77% +$15.6K ﹤0.01% 2138
2018
Q2
$25K Sell
52
-19
-27% -$4.86K ﹤0.01% 2158
2018
Q1
$18K Hold
71
﹤0.01% 2222
2017
Q4
$16K Buy
71
+14
+25% +$3.97K ﹤0.01% 2189
2017
Q3
$14K Buy
+57
New +$18.4K ﹤0.01% 2217

Other funds holding XBIO

Panagora Asset Management's XBIO Position: Q3 2019 in Review

Panagora Asset Management sold out of Xenetic Biosciences (XBIO) in Q3 2019, closing a stake of 34 shares — an estimated $4K sold.

Panagora Asset Management first reported a position in XBIO in Q3 2017 and held it in 8 quarters. The position peaked at $32K in Q1 2019. 8 funds tracked by Wall St. Rank hold XBIO as of Q3 2019.

  • Panagora Asset Management reported no remaining Xenetic Biosciences position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 34 Xenetic Biosciences shares in Q3 2019, an estimated $4K.
  • Panagora Asset Management first reported a position in Xenetic Biosciences in Q3 2017 and held it in 8 quarters.
  • Panagora Asset Management's Xenetic Biosciences position peaked at $32K in Q1 2019.
  • 8 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.